104 related articles for article (PubMed ID: 14971521)
21. Predictive value of lung function below the normal range and respiratory symptoms for progression of chronic obstructive pulmonary disease.
Albers M; Schermer T; Heijdra Y; Molema J; Akkermans R; van Weel C
Thorax; 2008 Mar; 63(3):201-7. PubMed ID: 17905823
[TBL] [Abstract][Full Text] [Related]
22. Factors that delay COPD detection in the general elderly population.
Horie J; Murata S; Hayashi S; Murata J; Miyazaki J; Mizota K; Horikawa E
Respir Care; 2011 Aug; 56(8):1143-50. PubMed ID: 21496370
[TBL] [Abstract][Full Text] [Related]
23. Assessment of pulmonary function in COPD.
Cooper CB
Semin Respir Crit Care Med; 2005 Apr; 26(2):246-52. PubMed ID: 16088441
[TBL] [Abstract][Full Text] [Related]
24. Case-finding options for COPD: results from the Burden of Obstructive Lung Disease study.
Jithoo A; Enright PL; Burney P; Buist AS; Bateman ED; Tan WC; Studnicka M; Mejza F; Gillespie S; Vollmer WM;
Eur Respir J; 2013 Mar; 41(3):548-55. PubMed ID: 22743668
[TBL] [Abstract][Full Text] [Related]
25. Classifying the severity of COPD: are the new severity scales better than the old?
Esteban C; Quintana JM; Egurrola M; Moraza J; Aburto M; Pérez-Izquierdo J; Basualdo LV; Capelastegui A
Int J Tuberc Lung Dis; 2009 Jun; 13(6):783-90. PubMed ID: 19460257
[TBL] [Abstract][Full Text] [Related]
26. [Comments on screening spirometry for detection of COPD].
van den Berg JW; van der Molen T; Kerstjens HA; Quanjer PH
Ned Tijdschr Geneeskd; 2007 Jul; 151(28):1557-60. PubMed ID: 17715762
[TBL] [Abstract][Full Text] [Related]
27. Cost-effectiveness of screening for albuminuria with subsequent fosinopril treatment to prevent cardiovascular events: A pharmacoeconomic analysis linked to the prevention of renal and vascular endstage disease (PREVEND) study and the prevention of renal and vascular endstage disease intervention trial (PREVEND IT).
Atthobari J; Asselbergs FW; Boersma C; de Vries R; Hillege HL; van Gilst WH; Gansevoort RT; de Jong PE; de Jong-van den Berg LT; Postma MJ;
Clin Ther; 2006 Mar; 28(3):432-44. PubMed ID: 16750458
[TBL] [Abstract][Full Text] [Related]
28. Screening of cognitive impairment in chronic obstructive pulmonary disease.
Antonelli-Incalzi R; Corsonello A; Trojano L; Pedone C; Acanfora D; Spada A; Izzo O; Rengo F
Dement Geriatr Cogn Disord; 2007; 23(4):264-70. PubMed ID: 17351318
[TBL] [Abstract][Full Text] [Related]
29. Questions for COPD diagnostic screening in a primary care setting.
Freeman D; Nordyke RJ; Isonaka S; Nonikov DV; Maroni JM; Price D; Halbert RJ
Respir Med; 2005 Oct; 99(10):1311-8. PubMed ID: 16140231
[TBL] [Abstract][Full Text] [Related]
30. Implications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: a community study.
Johannessen A; Omenaas ER; Bakke PS; Gulsvik A
Thorax; 2005 Oct; 60(10):842-7. PubMed ID: 16085729
[TBL] [Abstract][Full Text] [Related]
31. Development of a population-based screening questionnaire for COPD.
Calverley PM; Nordyke RJ; Halbert RJ; Isonaka S; Nonikov D
COPD; 2005 Jun; 2(2):225-32. PubMed ID: 17136949
[TBL] [Abstract][Full Text] [Related]
32. Accuracy and cost-effectiveness of different screening strategies for identifying undiagnosed COPD among primary care patients (≥40 years) in China: a cross-sectional screening test accuracy study: findings from the Breathe Well group.
Pan Z; Dickens AP; Chi C; Kong X; Enocson A; G Cooper B; Adab P; Cheng KK; Sitch AJ; Jowett S; Adams R; Correia-de-Sousa J; Farley A; Gale NK; Jolly K; Maglakelidze M; Maglakelidze T; M Martins S; Stavrikj K; Stelmach R; Turner AM; Williams S; E Jordan R
BMJ Open; 2021 Sep; 11(9):e051811. PubMed ID: 34556515
[TBL] [Abstract][Full Text] [Related]
33. Prevalence and incidence of depression in the Thai elderly.
Thongtang O; Sukhatunga K; Ngamthipwatthana T; Chulakadabba S; Vuthiganond S; Pooviboonsuk P; Kooptiwoot S; Phattharayuttawat S
J Med Assoc Thai; 2002 May; 85(5):540-4. PubMed ID: 12188382
[TBL] [Abstract][Full Text] [Related]
34. A BOLD statement on how to case-find moderate/severe COPD.
Steenbruggen I; Zielinski J; Lange P; Price D; Soriano JB
Eur Respir J; 2013 Mar; 41(3):503-4. PubMed ID: 23456932
[No Abstract] [Full Text] [Related]
35. Comparative Study on Chronic Obstructive Pulmonary Disease Screening Tools in Primary Healthcare Institutions in Beijing, China.
Yang X; Yao M; Yin D; Zhang N; Li J; Jiang Y; Fu R; Qian Y
Int J Chron Obstruct Pulmon Dis; 2023; 18():1773-1781. PubMed ID: 37608835
[TBL] [Abstract][Full Text] [Related]
36. Peak expiratory flow rate as predictor of inpatient death in patients with chronic obstructive pulmonary disease.
de la Iglesia F; Díaz JL; Pita S; Nicolás R; Ramos V; Pellicer C; Diz-Lois F
South Med J; 2005 Mar; 98(3):266-72. PubMed ID: 15813152
[TBL] [Abstract][Full Text] [Related]
37. [Function tests and the peak flow measurement in the diagnosis of obstructive diseases in the elderly].
Salgueiro Rodríguez M; Alvarez Dobaño JM; Valle Vázquez JM; Tumbeiro Nóvoa JM; Valdés Cuadrado LG; Carreira Villamor JM; Rodríguez Suárez JR
An Med Interna; 1991 Aug; 8(8):411-2. PubMed ID: 1768754
[No Abstract] [Full Text] [Related]
38. [Value of measurement of peak flow (peak expiratory flow rate Vmx50) in epidemiological surveys in chronic bronchitis].
Dutu S; Jienescu Z
Bronches; 1975; 25(2):148-51. PubMed ID: 1220841
[No Abstract] [Full Text] [Related]
39. The Peak Flow Working Group: test of portable peak flow meters by explosive decompression.
Pedersen OF; Miller MR
Eur Respir J Suppl; 1997 Feb; 24():23S-25S. PubMed ID: 9098705
[TBL] [Abstract][Full Text] [Related]
40. Measuring the profitability of a hospital pulmonary function laboratory: a case study.
Kocakülâh MC; Morris JT; Kessler B
J Health Care Finance; 2011; 37(4):36-45. PubMed ID: 21812353
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
